Some pharma companies promise to cover abortion-related travel costs — while others won't go that far yet - Endpoints News

Unlock this story instantly and join 144,500+ biopharma pros reading Endpoints daily — and it's free.

The private pharma player confirmed to Endpoints News that it had shuttered a study testing spesolimab as a therapy for Crohn’s patients suffering from bowel obstructions.

A spokesperson for the company tells Endpoints:.

The first phase of the work is almost done, the company says in a statement to Endpoints News.

Unlock this story instantly and join 144,500+ biopharma pros reading Endpoints daily — and it's free.

Unlock this story instantly and join 144,500+ biopharma pros reading Endpoints daily — and it's free.

Indian-based generics manufacturer Aurobindo Pharma has been in the crosshairs of the FDA for several years now, but the company is also attracting attention from regulators within the subcontinent.

According to the Indian business news site Business Standard, a warning letter was sent to the company from the Securities Exchange Board of India, or SEBI.

Unlock this story instantly and join 144,500+ biopharma pros reading Endpoints daily — and it's free.

Spero Therapeutics has been struggling in the past few years, dealing with FDA holds and staff reductions amidst a rough biotech market, and the latest news from the Massachusetts-based company confirms what it anticipated in May: a CRL.

© Endpoints Company 2022

ENDPOINTS NEWS Daily at 11:30 AM ET

ENDPOINTS PHARMA Daily at 2 PM ET